Rapport Therapeutics RAPP
NASDAQ RAPP
$46.49 -1.16 (-2.43%)
As of: Sep 4, 2026 · 2:34 PM EDT

Rapport Therapeutics (RAPP) Price to Earnings (2024 - 2026)

Analysis

Rapport Therapeutics (RAPP) Price to Earnings (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.30 Bn 131.45 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.70 Bn 77.70 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.33 Bn 1.37 Bn
4 Moderna 58.00 Bn 52.86 Bn 52.00 Mn
5 Revolution Medicines 44.18 Bn 44.18 Bn -
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.23 Bn 31.93 Bn 992.69 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 Rapport Therapeutics 2.22 Bn 2.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.30
Mar 31, 2026 -75.33
Dec 31, 2025 -34.99
Sep 30, 2025 -41.84
Jun 30, 2025 -15.52
Mar 31, 2025 -15.21
Dec 31, 2024 -18.41
Sep 30, 2024 -42.71
Jun 30, 2024 -13.69